Delfi Diagnostics
Baltimore
About Delfi Diagnostics
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $364.8M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Dec 2025)
- Website: delfidiagnostics.com
- Phone: 410-696-3304
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/delfi-diagnostics-26944 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.